A diverse body of evidence indicates a role for the lipid biomediator
lysophosphatidic acid (LPA) in the CNS. This study identifies and char
acterizes the induction of neuronal death by LPA. Treatment of culture
d hippocampal neurons from embryonic rat brains with 50 mu M LPA resul
ted in neuronal necrosis, as determined morphologically and by the rel
ease of lactate dehydrogenase. A concentration of LPA as low as 10 mu
M led to the release of lactate dehydrogenase. In contrast, treatment
of neurons with 0.1 or 1.0 mu M LPA resulted in apoptosis, as determin
ed by chromatin condensation. In addition, neuronal death induced by 1
mu M LPA was characterized as apoptotic on the basis of terminal dUTP
nick end-labeling (TUNEL) staining, externalization of phosphatidylse
rine, and protection against chromatin condensation, TUNEL staining, a
nd phosphatidylserine externalization by treatment with N-benzyloxycar
bonyl-Val-Ala-Asp-fluoromethyl ketone, a broad-spectrum inhibitor of c
aspases, i.e., members of the interleukin-1 beta converting enzyme fam
ily. Studies with antagonists of ionotropic glutamate receptors did no
t indicate;a significant role-for these receptors in apoptosis induced
by 1 mu M LPA. LPA (1 mu M) also induced a decrease in mitochondrial
membrane potential. Moreover, pretreatment of neurons with cyclosporin
A protected against the LPA-induced decrease in mitochondrial membran
e potential and neuronal apoptosis. Thus, LPA, at pathophysiological l
evels, can induce neuronal apoptosis and could thereby participate in
neurodegenerative disorders.